In contrast, we found that hepatic overexpression of Map2k6 reduced adiposity, and plasma glucose and insulin, indicating that liver regulation of Map2k6 may be pivotal for metabolic disease development. This evidence concerns the gene MAP2K6 and Other metabolic disease.